Clinical Trials Browser

EGF-R Positive Non-Small Cell Lung Cancer × icotinib × Clear all

NCT03749213 2018-11-21

Icotinib as Neoadjuvant Therapy in EGFR-mutant Stage ⅢA-N2 Non-small Cell Lung Cancer

Phase 2 Unknown

EGF-R Positive Non-Small Cell Lung Cancer

NCT03349203 2018-07-18

Icotinib as Neoadjuvant and Adjuvant Therapy in EGFR-mutant Stage IIIB or Oligometastasis Non-small Cell Lung Cancer

Phase 2 Unknown

EGF-R Positive Non-Small Cell Lung Cancer